# Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder.

> **NCT01148316** · NA · COMPLETED · sponsor: **Roseli Shavitt** · enrollment: 144 (actual)

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** fluoxetine
- **BEHAVIORAL:** Group cognitive-behavioral therapy

## Key facts

- **NCT ID:** NCT01148316
- **Lead sponsor:** Roseli Shavitt
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2013-06
- **Final completion:** 2013-12
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2014-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148316, "Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder.". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01148316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*